Donate

Blog

Diabetes burnout: a common but neglected impact of diabetes

Diabetes burnout: a common but neglected impact of diabetes

Research conducted by T1International finds that people living with diabetes are experiencing diabetes burnout at a very high rate, with a significant impact on their health and wellbeing. Read more

T1I’s Top 14 of 2022: A Year in Review

T1I’s Top 14 of 2022: A Year in Review

With many successes and key moments to reflect on, it is nearly impossible to recap all in a single post. Instead, you can hear favorite moments directly from the 14 members of the T1International team! Read more

Health is Wealth: Direct Action Recap

Health is Wealth: Direct Action Recap

Voices from around the world were part of the T1International Rally and March outside Eli Lilly on October 24th, where #insulin4all activists demanded Eli Lilly immediately lower the list price of insulin and defended the lives of those who are rationing insulin just to survive. Read more

New Rationing Data Reinforces T1International’s Call for Insulin Price Cap

New Rationing Data Reinforces T1International’s Call for Insulin Price Cap

A recent study of 2021 National Health Interview Survey data demonstrates what #insulin4all advocates have been saying for years: too many people are dangerously rationing insulin due to cost. While insulin costs around $6 to manufacture, three companies dominate more than 90% of the insulin market and charge around $300 for a single vial of insulin. Read more

Taking Action for Health is Wealth

Taking Action for Health is Wealth

T1International’s virtual #insulin4all Summit, Health is Wealth, was held on September 24th. Thank you everyone for your participation and read our recap here! Read more

The Long Road to US Federal Insulin Law and What More Needs to be Done

The Long Road to US Federal Insulin Law and What More Needs to be Done

The journey to move towards a federal insulin price cap has been long and difficult, including challenging incremental steps. The fight for a true insulin price cap in the US continues. Read more

5 Ways To Combat Pharma Talking Points with Just the Facts

5 Ways To Combat Pharma Talking Points with Just the Facts

Misinformation about diabetes and insulin is all too regularly spread in both the media and on social platforms. In this post, we outline 5 of the most common talking points used to explain away price gouging and how we can use the facts to overcome this narrative. Read more

Calling for Empowered Implementation of Global Diabetes Coverage Targets

Calling for Empowered Implementation of Global Diabetes Coverage Targets

At the 75th World Health Assembly (WHA) of the World Health Organization (WHO), member states adopted the first ever ‘Global Diabetes Coverage Targets,’ meant to steer the course of diabetes diagnosis and treatment for the next 8 years. Read more

The Realities of Diabetes Burnout

The Realities of Diabetes Burnout

For too long, understanding the precise relationship between burnout and diabetes has been a mystery, and more data must be uncovered. Working with T1International, we are sharing a new survey on the impacts and implications of burnout for those with type 1 diabetes. Read more

T1International’s 2022 Out-of-Pocket Cost Survey: An Easy Way to Advocate

T1International’s 2022 Out-of-Pocket Cost Survey: An Easy Way to Advocate

Take the Survey! The survey is for individuals over the age of 18 with type 1 diabetes. A parent or caregiver can take the survey for those under the age of 18. Caregivers can also take the survey for spouses or partners. The survey is anonymous and is completely optional. Read more